Denali Therapeutics - South San Francisco, California
Address: 161 Oyster Point Blvd Suite 200, South San Francisco, CA 94080.
Phone: 6508668548.
Website: denalitherapeutics.com
Specialties: Research institute, Biotechnology company.
Other points of interest: Wheelchair accessible entrance, Wheelchair accessible parking lot.
Opinions: This company has 15 reviews on Google My Business.
Average opinion: 3.9/5.
📌 Location of Denali Therapeutics
⏰ Open Hours of Denali Therapeutics
- Monday: 8 AM–7 PM
- Tuesday: 8 AM–7 PM
- Wednesday: 8 AM–7 PM
- Thursday: 8 AM–7 PM
- Friday: 8 AM–7 PM
- Saturday: Closed
- Sunday: Closed
Denali Therapeutics: A Leading Biotechnology Company in Neurodegenerative Disease Research
Address: 161 Oyster Point Blvd Suite 200, South San Francisco, CA 94080
Phone: 6508668548
Website: denalitherapeutics.com
Specialties: Denali Therapeutics is a premier research institute and biotechnology company focused on developing novel treatments for neurodegenerative diseases and other neurological conditions. Their cutting-edge research and innovative approaches have garnered significant attention in the scientific community.
Other points of interest: Wheelchair accessible entrance, Wheelchair accessible parking lot
Opinions: This company has received 15 reviews on Google My Business, with an average opinion of 3.9/5.
Denali Therapeutics has built a highly committed and bright team that pursues a comprehensive approach to tackling neurodegenerative disease and other neurological conditions. The company's dedication to patient care and their pursuit of groundbreaking science have earned them a strong reputation in the industry.
The team at Denali Therapeutics consists of awesome people who are passionate about their work and committed to making a positive impact on the lives of those suffering from neurodegenerative diseases. Their innovative science, top talent, and driven leadership have positioned them for a bright future.
With a wheelchair accessible entrance and wheelchair accessible parking lot, Denali Therapeutics demonstrates its commitment to providing equal access and opportunities for all individuals.